These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11449627)

  • 1. [Monoclonal antibodies: development and clinical prospects].
    Borchmann P; Riethmüller G; Engert A
    Internist (Berl); 2001 Jun; 42(6):803-4, 807-14. PubMed ID: 11449627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy].
    Renner C; Pfreundschuh M
    Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies. Targeted treatment.
    Mayo Clin Health Lett; 2003 Mar; 21(3):1-3. PubMed ID: 12703461
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody drug conjugates - Trojan horses in the war on cancer.
    Iyer U; Kadambi VJ
    J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies as specific tumor therapy agents. Wishful thinking or reality?].
    Gramatzki M; Valerius T
    Internist (Berl); 1997 Nov; 38(11):1055-62. PubMed ID: 9453954
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185.
    Boyer CM; Pusztai L; Wiener JR; Xu FJ; Dean GS; Bast BS; O'Briant KC; Greenwald M; DeSombre KA; Bast RC
    Int J Cancer; 1999 Aug; 82(4):525-31. PubMed ID: 10404066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immunotoxin therapy of cancer: advances and prospects.
    Wawrzynczak EJ
    Br J Cancer; 1991 Oct; 64(4):624-30. PubMed ID: 1911210
    [No Abstract]   [Full Text] [Related]  

  • 8. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
    Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody conjugates for the treatment of cancer.
    Pietersz GA; McKenzie IF
    Immunol Rev; 1992 Oct; 129():57-80. PubMed ID: 1464422
    [No Abstract]   [Full Text] [Related]  

  • 10. Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
    Ferrini S; Sforzini S; Canevari S
    Methods Mol Biol; 2001; 166():177-92. PubMed ID: 11217367
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application?
    Oldham RK
    J Biol Response Mod; 1987 Jun; 6(3):227-34. PubMed ID: 3298552
    [No Abstract]   [Full Text] [Related]  

  • 12. Where are the immunotoxins in the clinic?
    Beijnen JH
    Pharm World Sci; 1993 Aug; 15(4):145. PubMed ID: 8220296
    [No Abstract]   [Full Text] [Related]  

  • 13. EGF mutant receptor vIII as a molecular target in cancer therapy.
    Kuan CT; Wikstrand CJ; Bigner DD
    Endocr Relat Cancer; 2001 Jun; 8(2):83-96. PubMed ID: 11397666
    [No Abstract]   [Full Text] [Related]  

  • 14. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A magic bullet for cancer--how near and how far?
    Schnipper LE; Strom TB
    N Engl J Med; 2001 Jul; 345(4):283-4. PubMed ID: 11474668
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
    Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
    Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-guided radiation therapy of cancer.
    Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies: solid tumors.
    Spitler LE
    Cancer Treat Res; 1988; 37():493-514. PubMed ID: 2908641
    [No Abstract]   [Full Text] [Related]  

  • 19. Concepts of antibody-mediated cancer therapy.
    Kummer U; Staerz UD
    Cancer Invest; 1993; 11(2):174-84. PubMed ID: 8462018
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies in antibody therapy of cancer.
    Wawrzynczak EJ; Davies AJ
    Clin Exp Immunol; 1990 Nov; 82(2):189-93. PubMed ID: 2242603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.